Lisdexamfetaminä Stada

Lisdexamfetamine Dimesylate is a prescription medication used to manage ADHD and promote weight loss. This oral medication is manufactured by Stada M&d S.R.L. and is available in the EU market.

Lisdexamfetamine Dimesylate is commonly used to treat attention deficit hyperactivity disorder (ADHD) in both children and adults. It helps improve focus, reduce impulsivity, and enhance concentration. Additionally, it is prescribed for weight management in adults with obesity, particularly when combined with a reduced-calorie diet and increased physical activity. The medication works by increasing certain chemicals in the brain that contribute to hyperactivity and impulse control.

Common effects of Lisdexamfetamine Dimesylate may include increased alertness, improved focus, and reduced appetite. Some users may experience side effects such as dry mouth, insomnia, decreased appetite, and mild stomach upset. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Lisdexamfetamine Dimesylate should be handled with care and stored in a safe place to prevent misuse. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms. Always consult a healthcare provider before starting or stopping any medication.

Lisdexamfetamine Dimesylate may interact with certain medications, including monoamine oxidase inhibitors (MAOIs), antidepressants, and other stimulants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, consuming alcohol while taking this medication may increase the risk of side effects and should be avoided.